Thus, our data indicated that mutations in RAS pathway involving KRAS, NRAS, and PTPN11 genes were the most common genetic alterations observed in 11q23/KMT2A‐rearranged AML pediatric patients. This evidence concerns the gene NRAS and acute myeloid leukemia.